Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptigon Capital
Chicago, Illinois, United States
- Ownership
- Private
- Employees
- ~63
- Development stage
- Other
01
Overview
Aptigon Capital was a fundamental equities investing business operated as a Citadel-affiliated investment unit rather than a life sciences or healthcare operating company. The firm focused on public-equity investing and used Citadel's risk management and technology infrastructure to build market-neutral portfolios across sectors, including healthcare. Public profiles describe Aptigon as a private Chicago-based financial services business founded in 2016. Multiple sources indicate the business was later shut down and is no longer active. It does not appear to have drug programs, a therapeutic pipeline, or healthcare products and services of its own.
- Industry
- Investors
Beyond the preview
Go deeper on Aptigon Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aptigon Capital.